nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrofurantoin—ABCG2—Leflunomide—systemic scleroderma	0.372	0.536	CbGbCtD
Nitrofurantoin—ABCG2—Mycophenolate mofetil—systemic scleroderma	0.23	0.331	CbGbCtD
Nitrofurantoin—ABCG2—Methotrexate—systemic scleroderma	0.0921	0.133	CbGbCtD
Nitrofurantoin—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000591	0.00193	CcSEcCtD
Nitrofurantoin—Abdominal pain—Mometasone—systemic scleroderma	0.000589	0.00192	CcSEcCtD
Nitrofurantoin—Body temperature increased—Mometasone—systemic scleroderma	0.000589	0.00192	CcSEcCtD
Nitrofurantoin—Discomfort—Azathioprine—systemic scleroderma	0.000589	0.00192	CcSEcCtD
Nitrofurantoin—Paraesthesia—Captopril—systemic scleroderma	0.000588	0.00192	CcSEcCtD
Nitrofurantoin—Chills—Lisinopril—systemic scleroderma	0.000585	0.00191	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.000585	0.00191	CcSEcCtD
Nitrofurantoin—Dyspnoea—Captopril—systemic scleroderma	0.000584	0.0019	CcSEcCtD
Nitrofurantoin—Anaemia—Mycophenolic acid—systemic scleroderma	0.000583	0.0019	CcSEcCtD
Nitrofurantoin—Somnolence—Captopril—systemic scleroderma	0.000582	0.0019	CcSEcCtD
Nitrofurantoin—Cough—Leflunomide—systemic scleroderma	0.000577	0.00188	CcSEcCtD
Nitrofurantoin—Alopecia—Lisinopril—systemic scleroderma	0.000577	0.00188	CcSEcCtD
Nitrofurantoin—Dyspepsia—Captopril—systemic scleroderma	0.000576	0.00188	CcSEcCtD
Nitrofurantoin—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.000572	0.00187	CcSEcCtD
Nitrofurantoin—Dizziness—Pentoxifylline—systemic scleroderma	0.000571	0.00186	CcSEcCtD
Nitrofurantoin—Decreased appetite—Captopril—systemic scleroderma	0.000569	0.00186	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.000569	0.00186	CcSEcCtD
Nitrofurantoin—Malaise—Mycophenolic acid—systemic scleroderma	0.000569	0.00186	CcSEcCtD
Nitrofurantoin—Vertigo—Mycophenolic acid—systemic scleroderma	0.000567	0.00185	CcSEcCtD
Nitrofurantoin—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000564	0.00184	CcSEcCtD
Nitrofurantoin—Chest pain—Leflunomide—systemic scleroderma	0.000563	0.00184	CcSEcCtD
Nitrofurantoin—Myalgia—Leflunomide—systemic scleroderma	0.000563	0.00184	CcSEcCtD
Nitrofurantoin—Constipation—Captopril—systemic scleroderma	0.00056	0.00183	CcSEcCtD
Nitrofurantoin—Flatulence—Lisinopril—systemic scleroderma	0.00056	0.00183	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000559	0.00183	CcSEcCtD
Nitrofurantoin—Discomfort—Leflunomide—systemic scleroderma	0.000556	0.00181	CcSEcCtD
Nitrofurantoin—Cough—Mycophenolic acid—systemic scleroderma	0.00055	0.0018	CcSEcCtD
Nitrofurantoin—Vomiting—Pentoxifylline—systemic scleroderma	0.000549	0.00179	CcSEcCtD
Nitrofurantoin—Psychotic disorder—Prednisone—systemic scleroderma	0.000547	0.00179	CcSEcCtD
Nitrofurantoin—Rash—Pentoxifylline—systemic scleroderma	0.000545	0.00178	CcSEcCtD
Nitrofurantoin—Headache—Pentoxifylline—systemic scleroderma	0.000541	0.00177	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000539	0.00176	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Captopril—systemic scleroderma	0.000539	0.00176	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Methotrexate—systemic scleroderma	0.000538	0.00176	CcSEcCtD
Nitrofurantoin—Myalgia—Mycophenolic acid—systemic scleroderma	0.000537	0.00175	CcSEcCtD
Nitrofurantoin—Chest pain—Mycophenolic acid—systemic scleroderma	0.000537	0.00175	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Captopril—systemic scleroderma	0.000535	0.00175	CcSEcCtD
Nitrofurantoin—Asthenia—Mometasone—systemic scleroderma	0.000535	0.00175	CcSEcCtD
Nitrofurantoin—Discomfort—Mycophenolic acid—systemic scleroderma	0.00053	0.00173	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000528	0.00172	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000527	0.00172	CcSEcCtD
Nitrofurantoin—Anaemia—Lisinopril—systemic scleroderma	0.000525	0.00171	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00052	0.0017	CcSEcCtD
Nitrofurantoin—Confusional state—Mycophenolic acid—systemic scleroderma	0.000519	0.00169	CcSEcCtD
Nitrofurantoin—Abdominal pain—Captopril—systemic scleroderma	0.000517	0.00169	CcSEcCtD
Nitrofurantoin—Body temperature increased—Captopril—systemic scleroderma	0.000517	0.00169	CcSEcCtD
Nitrofurantoin—Anorexia—Leflunomide—systemic scleroderma	0.000514	0.00168	CcSEcCtD
Nitrofurantoin—Nausea—Pentoxifylline—systemic scleroderma	0.000513	0.00167	CcSEcCtD
Nitrofurantoin—Chills—Mycophenolate mofetil—systemic scleroderma	0.000513	0.00167	CcSEcCtD
Nitrofurantoin—Malaise—Lisinopril—systemic scleroderma	0.000512	0.00167	CcSEcCtD
Nitrofurantoin—Vertigo—Lisinopril—systemic scleroderma	0.00051	0.00167	CcSEcCtD
Nitrofurantoin—Diarrhoea—Mometasone—systemic scleroderma	0.00051	0.00166	CcSEcCtD
Nitrofurantoin—Leukopenia—Lisinopril—systemic scleroderma	0.000508	0.00166	CcSEcCtD
Nitrofurantoin—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000505	0.00165	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000504	0.00164	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.000496	0.00162	CcSEcCtD
Nitrofurantoin—Cough—Lisinopril—systemic scleroderma	0.000496	0.00162	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.000494	0.00161	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000493	0.00161	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000492	0.0016	CcSEcCtD
Nitrofurantoin—Anorexia—Mycophenolic acid—systemic scleroderma	0.000491	0.0016	CcSEcCtD
Nitrofurantoin—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00049	0.0016	CcSEcCtD
Nitrofurantoin—Paraesthesia—Leflunomide—systemic scleroderma	0.000484	0.00158	CcSEcCtD
Nitrofurantoin—Myalgia—Lisinopril—systemic scleroderma	0.000484	0.00158	CcSEcCtD
Nitrofurantoin—Chest pain—Lisinopril—systemic scleroderma	0.000484	0.00158	CcSEcCtD
Nitrofurantoin—Dyspnoea—Leflunomide—systemic scleroderma	0.000481	0.00157	CcSEcCtD
Nitrofurantoin—Discomfort—Lisinopril—systemic scleroderma	0.000478	0.00156	CcSEcCtD
Nitrofurantoin—Dyspepsia—Leflunomide—systemic scleroderma	0.000475	0.00155	CcSEcCtD
Nitrofurantoin—Vomiting—Mometasone—systemic scleroderma	0.000474	0.00155	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Azathioprine—systemic scleroderma	0.000471	0.00154	CcSEcCtD
Nitrofurantoin—Rash—Mometasone—systemic scleroderma	0.00047	0.00153	CcSEcCtD
Nitrofurantoin—Asthenia—Captopril—systemic scleroderma	0.00047	0.00153	CcSEcCtD
Nitrofurantoin—Decreased appetite—Leflunomide—systemic scleroderma	0.000469	0.00153	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000469	0.00153	CcSEcCtD
Nitrofurantoin—Confusional state—Lisinopril—systemic scleroderma	0.000467	0.00153	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000467	0.00152	CcSEcCtD
Nitrofurantoin—Headache—Mometasone—systemic scleroderma	0.000467	0.00152	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000466	0.00152	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000464	0.00151	CcSEcCtD
Nitrofurantoin—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000462	0.00151	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000462	0.00151	CcSEcCtD
Nitrofurantoin—Constipation—Leflunomide—systemic scleroderma	0.000461	0.00151	CcSEcCtD
Nitrofurantoin—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00046	0.0015	CcSEcCtD
Nitrofurantoin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000459	0.0015	CcSEcCtD
Nitrofurantoin—Somnolence—Mycophenolic acid—systemic scleroderma	0.000458	0.00149	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000454	0.00148	CcSEcCtD
Nitrofurantoin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000453	0.00148	CcSEcCtD
Nitrofurantoin—Abdominal pain—Azathioprine—systemic scleroderma	0.000452	0.00147	CcSEcCtD
Nitrofurantoin—Body temperature increased—Azathioprine—systemic scleroderma	0.000452	0.00147	CcSEcCtD
Nitrofurantoin—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000449	0.00146	CcSEcCtD
Nitrofurantoin—Diarrhoea—Captopril—systemic scleroderma	0.000448	0.00146	CcSEcCtD
Nitrofurantoin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000447	0.00146	CcSEcCtD
Nitrofurantoin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000447	0.00146	CcSEcCtD
Nitrofurantoin—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000445	0.00145	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Leflunomide—systemic scleroderma	0.000445	0.00145	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000444	0.00145	CcSEcCtD
Nitrofurantoin—Nausea—Mometasone—systemic scleroderma	0.000443	0.00144	CcSEcCtD
Nitrofurantoin—Anorexia—Lisinopril—systemic scleroderma	0.000442	0.00144	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000441	0.00144	CcSEcCtD
Nitrofurantoin—Constipation—Mycophenolic acid—systemic scleroderma	0.00044	0.00144	CcSEcCtD
Nitrofurantoin—Cough—Mycophenolate mofetil—systemic scleroderma	0.000434	0.00142	CcSEcCtD
Nitrofurantoin—Dizziness—Captopril—systemic scleroderma	0.000433	0.00141	CcSEcCtD
Nitrofurantoin—Abdominal pain—Leflunomide—systemic scleroderma	0.000426	0.00139	CcSEcCtD
Nitrofurantoin—Body temperature increased—Leflunomide—systemic scleroderma	0.000426	0.00139	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000424	0.00138	CcSEcCtD
Nitrofurantoin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000424	0.00138	CcSEcCtD
Nitrofurantoin—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000424	0.00138	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000423	0.00138	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000422	0.00138	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000421	0.00137	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000421	0.00137	CcSEcCtD
Nitrofurantoin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000419	0.00137	CcSEcCtD
Nitrofurantoin—Paraesthesia—Lisinopril—systemic scleroderma	0.000416	0.00136	CcSEcCtD
Nitrofurantoin—Vomiting—Captopril—systemic scleroderma	0.000416	0.00136	CcSEcCtD
Nitrofurantoin—Dyspnoea—Lisinopril—systemic scleroderma	0.000413	0.00135	CcSEcCtD
Nitrofurantoin—Rash—Captopril—systemic scleroderma	0.000413	0.00135	CcSEcCtD
Nitrofurantoin—Somnolence—Lisinopril—systemic scleroderma	0.000412	0.00135	CcSEcCtD
Nitrofurantoin—Headache—Captopril—systemic scleroderma	0.00041	0.00134	CcSEcCtD
Nitrofurantoin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00041	0.00134	CcSEcCtD
Nitrofurantoin—Dyspepsia—Lisinopril—systemic scleroderma	0.000408	0.00133	CcSEcCtD
Nitrofurantoin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000407	0.00133	CcSEcCtD
Nitrofurantoin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000407	0.00133	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000406	0.00133	CcSEcCtD
Nitrofurantoin—Asthma—Methotrexate—systemic scleroderma	0.000405	0.00132	CcSEcCtD
Nitrofurantoin—Decreased appetite—Lisinopril—systemic scleroderma	0.000403	0.00132	CcSEcCtD
Nitrofurantoin—Eosinophilia—Methotrexate—systemic scleroderma	0.000401	0.00131	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.0004	0.00131	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000398	0.0013	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000397	0.0013	CcSEcCtD
Nitrofurantoin—Constipation—Lisinopril—systemic scleroderma	0.000396	0.00129	CcSEcCtD
Nitrofurantoin—Diarrhoea—Azathioprine—systemic scleroderma	0.000391	0.00128	CcSEcCtD
Nitrofurantoin—Nausea—Captopril—systemic scleroderma	0.000389	0.00127	CcSEcCtD
Nitrofurantoin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000387	0.00126	CcSEcCtD
Nitrofurantoin—Asthenia—Leflunomide—systemic scleroderma	0.000387	0.00126	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000382	0.00125	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000379	0.00124	CcSEcCtD
Nitrofurantoin—Dizziness—Azathioprine—systemic scleroderma	0.000378	0.00123	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00037	0.00121	CcSEcCtD
Nitrofurantoin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000369	0.00121	CcSEcCtD
Nitrofurantoin—Diarrhoea—Leflunomide—systemic scleroderma	0.000369	0.0012	CcSEcCtD
Nitrofurantoin—Abdominal pain—Lisinopril—systemic scleroderma	0.000366	0.0012	CcSEcCtD
Nitrofurantoin—Body temperature increased—Lisinopril—systemic scleroderma	0.000366	0.0012	CcSEcCtD
Nitrofurantoin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000365	0.00119	CcSEcCtD
Nitrofurantoin—Vomiting—Azathioprine—systemic scleroderma	0.000363	0.00119	CcSEcCtD
Nitrofurantoin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000362	0.00118	CcSEcCtD
Nitrofurantoin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000361	0.00118	CcSEcCtD
Nitrofurantoin—Drowsiness—Methotrexate—systemic scleroderma	0.000361	0.00118	CcSEcCtD
Nitrofurantoin—Rash—Azathioprine—systemic scleroderma	0.00036	0.00118	CcSEcCtD
Nitrofurantoin—Headache—Azathioprine—systemic scleroderma	0.000358	0.00117	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000358	0.00117	CcSEcCtD
Nitrofurantoin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000358	0.00117	CcSEcCtD
Nitrofurantoin—Dizziness—Leflunomide—systemic scleroderma	0.000357	0.00116	CcSEcCtD
Nitrofurantoin—Renal failure—Methotrexate—systemic scleroderma	0.000355	0.00116	CcSEcCtD
Nitrofurantoin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000353	0.00115	CcSEcCtD
Nitrofurantoin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000352	0.00115	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000351	0.00114	CcSEcCtD
Nitrofurantoin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000347	0.00113	CcSEcCtD
Nitrofurantoin—Vomiting—Leflunomide—systemic scleroderma	0.000343	0.00112	CcSEcCtD
Nitrofurantoin—Alopecia—Prednisone—systemic scleroderma	0.000342	0.00112	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000342	0.00111	CcSEcCtD
Nitrofurantoin—Dizziness—Mycophenolic acid—systemic scleroderma	0.00034	0.00111	CcSEcCtD
Nitrofurantoin—Rash—Leflunomide—systemic scleroderma	0.00034	0.00111	CcSEcCtD
Nitrofurantoin—Nausea—Azathioprine—systemic scleroderma	0.000339	0.00111	CcSEcCtD
Nitrofurantoin—Headache—Leflunomide—systemic scleroderma	0.000338	0.0011	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Methotrexate—systemic scleroderma	0.000337	0.0011	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000335	0.00109	CcSEcCtD
Nitrofurantoin—Asthenia—Lisinopril—systemic scleroderma	0.000333	0.00109	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000332	0.00108	CcSEcCtD
Nitrofurantoin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000327	0.00107	CcSEcCtD
Nitrofurantoin—Rash—Mycophenolic acid—systemic scleroderma	0.000325	0.00106	CcSEcCtD
Nitrofurantoin—Hepatitis—Methotrexate—systemic scleroderma	0.000324	0.00106	CcSEcCtD
Nitrofurantoin—Headache—Mycophenolic acid—systemic scleroderma	0.000322	0.00105	CcSEcCtD
Nitrofurantoin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000321	0.00105	CcSEcCtD
Nitrofurantoin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000321	0.00105	CcSEcCtD
Nitrofurantoin—Nausea—Leflunomide—systemic scleroderma	0.00032	0.00105	CcSEcCtD
Nitrofurantoin—Diarrhoea—Lisinopril—systemic scleroderma	0.000317	0.00104	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Prednisone—systemic scleroderma	0.000313	0.00102	CcSEcCtD
Nitrofurantoin—Anaemia—Prednisone—systemic scleroderma	0.000312	0.00102	CcSEcCtD
Nitrofurantoin—Dizziness—Lisinopril—systemic scleroderma	0.000307	0.001	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Methotrexate—systemic scleroderma	0.000306	0.000999	CcSEcCtD
Nitrofurantoin—Nausea—Mycophenolic acid—systemic scleroderma	0.000306	0.000998	CcSEcCtD
Nitrofurantoin—Malaise—Prednisone—systemic scleroderma	0.000304	0.000993	CcSEcCtD
Nitrofurantoin—Vertigo—Prednisone—systemic scleroderma	0.000303	0.000989	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000299	0.000977	CcSEcCtD
Nitrofurantoin—Vomiting—Lisinopril—systemic scleroderma	0.000295	0.000962	CcSEcCtD
Nitrofurantoin—Rash—Lisinopril—systemic scleroderma	0.000292	0.000954	CcSEcCtD
Nitrofurantoin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000291	0.000951	CcSEcCtD
Nitrofurantoin—Chills—Methotrexate—systemic scleroderma	0.000291	0.000948	CcSEcCtD
Nitrofurantoin—Headache—Lisinopril—systemic scleroderma	0.00029	0.000948	CcSEcCtD
Nitrofurantoin—Myalgia—Prednisone—systemic scleroderma	0.000287	0.000937	CcSEcCtD
Nitrofurantoin—Alopecia—Methotrexate—systemic scleroderma	0.000286	0.000934	CcSEcCtD
Nitrofurantoin—Discomfort—Prednisone—systemic scleroderma	0.000284	0.000926	CcSEcCtD
Nitrofurantoin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000278	0.000907	CcSEcCtD
Nitrofurantoin—Nausea—Lisinopril—systemic scleroderma	0.000275	0.000899	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000275	0.000899	CcSEcCtD
Nitrofurantoin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000269	0.000877	CcSEcCtD
Nitrofurantoin—Anorexia—Prednisone—systemic scleroderma	0.000262	0.000857	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000262	0.000854	CcSEcCtD
Nitrofurantoin—Anaemia—Methotrexate—systemic scleroderma	0.000261	0.000851	CcSEcCtD
Nitrofurantoin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000258	0.000843	CcSEcCtD
Nitrofurantoin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000256	0.000836	CcSEcCtD
Nitrofurantoin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000254	0.000831	CcSEcCtD
Nitrofurantoin—Malaise—Methotrexate—systemic scleroderma	0.000254	0.00083	CcSEcCtD
Nitrofurantoin—Vertigo—Methotrexate—systemic scleroderma	0.000253	0.000827	CcSEcCtD
Nitrofurantoin—Leukopenia—Methotrexate—systemic scleroderma	0.000252	0.000824	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000251	0.000819	CcSEcCtD
Nitrofurantoin—Paraesthesia—Prednisone—systemic scleroderma	0.000247	0.000807	CcSEcCtD
Nitrofurantoin—Cough—Methotrexate—systemic scleroderma	0.000246	0.000803	CcSEcCtD
Nitrofurantoin—Dyspepsia—Prednisone—systemic scleroderma	0.000242	0.000791	CcSEcCtD
Nitrofurantoin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000241	0.000787	CcSEcCtD
Nitrofurantoin—Chest pain—Methotrexate—systemic scleroderma	0.00024	0.000783	CcSEcCtD
Nitrofurantoin—Myalgia—Methotrexate—systemic scleroderma	0.00024	0.000783	CcSEcCtD
Nitrofurantoin—Decreased appetite—Prednisone—systemic scleroderma	0.000239	0.000781	CcSEcCtD
Nitrofurantoin—Discomfort—Methotrexate—systemic scleroderma	0.000237	0.000774	CcSEcCtD
Nitrofurantoin—Constipation—Prednisone—systemic scleroderma	0.000235	0.000768	CcSEcCtD
Nitrofurantoin—Confusional state—Methotrexate—systemic scleroderma	0.000232	0.000757	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00023	0.000751	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Prednisone—systemic scleroderma	0.000227	0.000741	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000225	0.000735	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000225	0.000735	CcSEcCtD
Nitrofurantoin—Anorexia—Methotrexate—systemic scleroderma	0.000219	0.000716	CcSEcCtD
Nitrofurantoin—Abdominal pain—Prednisone—systemic scleroderma	0.000218	0.00071	CcSEcCtD
Nitrofurantoin—Body temperature increased—Prednisone—systemic scleroderma	0.000218	0.00071	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00021	0.000684	CcSEcCtD
Nitrofurantoin—Paraesthesia—Methotrexate—systemic scleroderma	0.000207	0.000674	CcSEcCtD
Nitrofurantoin—Dyspnoea—Methotrexate—systemic scleroderma	0.000205	0.00067	CcSEcCtD
Nitrofurantoin—Somnolence—Methotrexate—systemic scleroderma	0.000205	0.000668	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Prednisone—systemic scleroderma	0.000203	0.000662	CcSEcCtD
Nitrofurantoin—Dyspepsia—Methotrexate—systemic scleroderma	0.000203	0.000661	CcSEcCtD
Nitrofurantoin—Decreased appetite—Methotrexate—systemic scleroderma	0.0002	0.000653	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000199	0.000648	CcSEcCtD
Nitrofurantoin—Asthenia—Prednisone—systemic scleroderma	0.000198	0.000645	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Methotrexate—systemic scleroderma	0.00019	0.000619	CcSEcCtD
Nitrofurantoin—Diarrhoea—Prednisone—systemic scleroderma	0.000188	0.000615	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000188	0.000614	CcSEcCtD
Nitrofurantoin—Dizziness—Prednisone—systemic scleroderma	0.000182	0.000594	CcSEcCtD
Nitrofurantoin—Abdominal pain—Methotrexate—systemic scleroderma	0.000182	0.000594	CcSEcCtD
Nitrofurantoin—Body temperature increased—Methotrexate—systemic scleroderma	0.000182	0.000594	CcSEcCtD
Nitrofurantoin—Vomiting—Prednisone—systemic scleroderma	0.000175	0.000571	CcSEcCtD
Nitrofurantoin—Rash—Prednisone—systemic scleroderma	0.000174	0.000567	CcSEcCtD
Nitrofurantoin—Headache—Prednisone—systemic scleroderma	0.000172	0.000563	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Methotrexate—systemic scleroderma	0.00017	0.000553	CcSEcCtD
Nitrofurantoin—Asthenia—Methotrexate—systemic scleroderma	0.000165	0.000539	CcSEcCtD
Nitrofurantoin—Nausea—Prednisone—systemic scleroderma	0.000164	0.000534	CcSEcCtD
Nitrofurantoin—Diarrhoea—Methotrexate—systemic scleroderma	0.000157	0.000514	CcSEcCtD
Nitrofurantoin—Dizziness—Methotrexate—systemic scleroderma	0.000152	0.000497	CcSEcCtD
Nitrofurantoin—Vomiting—Methotrexate—systemic scleroderma	0.000146	0.000478	CcSEcCtD
Nitrofurantoin—Rash—Methotrexate—systemic scleroderma	0.000145	0.000474	CcSEcCtD
Nitrofurantoin—Headache—Methotrexate—systemic scleroderma	0.000144	0.00047	CcSEcCtD
Nitrofurantoin—Nausea—Methotrexate—systemic scleroderma	0.000137	0.000446	CcSEcCtD
